Quest Diagnostics (NYSE: DGX) CEO discloses 10,000-share stock sale

robot
Abstract generation in progress

Quest Diagnostics CEO and President J. E. Davis reported two stock transactions involving company common stock. He disposed of 2,968 shares to cover tax obligations from a restricted share unit grant and sold 10,000 shares in an open-market transaction under a pre-arranged Rule 10b5-1 sales plan. Following these transactions, he directly holds 117,185 Quest Diagnostics shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin